HOSPITAL SERVICES & SALES products and prices in Pakistan
Importer / marketer Its products are registered under a DRAP Drug Sale Licence (DSL), typically imported finished products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical and vaccine importer / registration holder · Karachi · Pakistan
Karachi healthcare company acting as registration holder/importer for vaccines and biological products, including products from international vaccine manufacturers.
HOSPITAL SERVICES & SALES products in Pakistan
HOSPITAL SERVICES & SALES has 10 medicine presentations registered in Pakistan under 7 brands, covering 7 generic medicines. Most of its products are in Vaccines & immunologicals. Its brands with the most registered strengths and packs are Rotasiil (Rotavirus vaccine, live attenuated), Tetanus Toxoid Vaccine Adsorbed (Tetanus toxoid), Yellow Fever Vaccine (Yellow fever vaccine, live attenuated) and Easyfive-TT (Diphtheria, tetanus, whole-cell pertussis, recombinant hepatitis B and Haemophilus influenzae type b conjugate vaccine). 10 products have an official DRAP price on MedInfoBase. See all 7 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical and vaccine importer / registration holder
- Address
- 13-B, Block 6, P.E.C.H.S., Shahrah-e-Faisal, Karachi, Pakistan
- Phone
- +92 21 34521629
- Corporate source details checked
- 30 Oct 2026
- Corporate profile completeness
- 63%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Easyfive-TT | Diphtheria, tetanus, whole-cell pertussis, recombinant hepatitis B and Haemophilus influenzae type b conjugate vaccine | 0.5 mL/dose | Injection | 0.5ml Vial / 1 Dose | 053813 | PKR 4,498.15 | — | No comparator |
| Indirab | Rabies vaccine, inactivated (purified Vero cell) | 2.5 IU/0.5 mL | Lyophilized vaccine for injection | 0.5 ml vial | 053814 | PKR 1,466.33 | PKR 2,932.66/mL | No comparator |
| Poliomyelitis Vaccine | Poliomyelitis vaccine, inactivated | 0.5 mL/dose (40/8/32 D-antigen units) | Suspension for injection | 0.5 ml Vial / 1 Dose | 077520 | PKR 875.67 | — | No comparator |
| Poliomyelitis vaccine (Inactivated) multidose, suspension for injectionRegistry verified | Poliomyelitis Vaccine, Inactivated – Suspension for injection | — | — | — | 137642Official source ↗ | No indexed price | — | — |
| Poliomyelitis vaccine (Inactivated) multidose, suspension for injection 10 Dose x 5 ml VialRegistry verified | Poliomyelitis vaccine (Inactivated) | — | — | — | 137643Official source ↗ | No indexed price | — | — |
| Rotasiil | Rotavirus vaccine, live attenuated | ≥10^5.6 FFU/serotype per 2.5 mL dose | Lyophilized oral vaccine with diluent | 1 Dose VaccineVial + 1 Diluent2.5ml Vial | 107974 | PKR 2,188.23 | — | No comparator |
| ROTASIIL | Rotavirus vaccine, live attenuated | ≥10^5.6 FFU/serotype per 2.5 mL dose | Oral freeze-dried vaccine with diluent | 2 Dose VaccineVial + 1 Diluent5 ml Vial | 107975 | PKR 4,290.28 | — | No comparator |
| SII-ONCO-BCG | Bacillus Calmette-Guerin (BCG) | 40 mg/mL | Injection | 40mg vial | 053818 | PKR 9,830.66 | — | No comparator |
| Tetanus Toxoid Vaccine Adsorbed | Tetanus toxoid | 5 Lf (40 IU)/0.5 mL dose | Vaccine injection | 5 ml vial | 053815 | PKR 566.84 | PKR 113.37/mL | No comparator |
| Tetanus Toxoid Vaccine Adsorbed | Tetanus toxoid | 40 IU | Vaccine | Box of 10 Amp. 0.5ml | 059004 | PKR 867.41 | — | No comparator |
| Yellow Fever Vaccine | Yellow fever vaccine, live attenuated | ≥1600 PFU/0.5 mL (or ≥1000 LD50) | Lyophilized vaccine for injection | 02 Doses Amp. / 1 ml | 077551 | PKR 5,274.34 | — | No comparator |
| Yellow Fever Vaccine | Yellow fever vaccine, live attenuated | ≥1600 PFU/0.5 mL (or ≥1000 LD50) | Lyophilized vaccine for injection | 05 Doses Amp. / 2.5 ml | 077553 | PKR 10,546.73 | — | No comparator |
All 7 HOSPITAL SERVICES & SALES brands in Pakistan
- Easyfive-TT Diphtheria, tetanus, whole-cell pertussis, recombinant hepatitis B and Haemophilus influenzae type b conjugate vaccine · 0.5 mL/dose injection
- Indirab Rabies vaccine, inactivated (purified Vero cell) · 2.5 IU/0.5 mL vaccine
- Poliomyelitis Vaccine Poliomyelitis vaccine, inactivated · 0.5 mL/dose (40/8/32 D-antigen units) injection
- Rotasiil Rotavirus vaccine, live attenuated · ≥10^5.6 FFU/serotype per 2.5 mL dose vaccine
- SII-ONCO-BCG Bacillus Calmette-Guerin (BCG) · 40 mg/mL injection
- Tetanus Toxoid Vaccine Adsorbed Tetanus toxoid · 40 IU vaccine, 5 Lf (40 IU)/0.5 mL dose vaccine
- Yellow Fever Vaccine Yellow fever vaccine, live attenuated · ≥1600 PFU/0.5 mL (or ≥1000 LD50) vaccine
HOSPITAL SERVICES & SALES: common questions
How many products does HOSPITAL SERVICES & SALES have in Pakistan?
HOSPITAL SERVICES & SALES has 10 registered medicine presentations in Pakistan, sold under 7 brands and covering 7 generic medicines.
What are the main brands of HOSPITAL SERVICES & SALES?
By number of registered strengths and packs, its largest brands are Rotasiil (Rotavirus vaccine, live attenuated), Tetanus Toxoid Vaccine Adsorbed (Tetanus toxoid), Yellow Fever Vaccine (Yellow fever vaccine, live attenuated), Easyfive-TT (Diphtheria, tetanus, whole-cell pertussis, recombinant hepatitis B and Haemophilus influenzae type b conjugate vaccine) and Indirab (Rabies vaccine, inactivated (purified Vero cell)). This is not a sales ranking.
Which therapy areas does HOSPITAL SERVICES & SALES cover?
The most products are in Vaccines & immunologicals (10).
Where can I see HOSPITAL SERVICES & SALES medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.